Cancer: Medical Treatments

(asked on 16th July 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the availability of (a) radioligand therapy and (b) short shelf-life medicines after the end of the transition period.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 20th August 2020

The United Kingdom’s published approach sets out how we want to facilitate trade in medicinal products, including radioligand therapy and short shelf-life medicines, to support high levels of patient safety.

We will continue to work closely with the pharmaceutical industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and that precautions are in place to reduce the likelihood of future shortages.

Reticulating Splines